| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyloid beta-Peptides | 229 | 2023 | 3587 | 15.630 |
Why?
|
| Alzheimer Disease | 266 | 2023 | 8037 | 11.960 |
Why?
|
| Amyloid beta-Protein Precursor | 140 | 2023 | 1121 | 11.020 |
Why?
|
| alpha-Synuclein | 44 | 2023 | 723 | 9.320 |
Why?
|
| Amyloid Precursor Protein Secretases | 74 | 2022 | 584 | 8.050 |
Why?
|
| Amyloid | 49 | 2023 | 795 | 3.800 |
Why?
|
| Endopeptidases | 48 | 2010 | 772 | 3.730 |
Why?
|
| Parkinson Disease | 32 | 2023 | 2775 | 3.600 |
Why?
|
| Long-Term Potentiation | 21 | 2022 | 293 | 3.160 |
Why?
|
| Neurons | 87 | 2023 | 9338 | 3.010 |
Why?
|
| tau Proteins | 32 | 2023 | 1868 | 3.010 |
Why?
|
| Plaque, Amyloid | 26 | 2023 | 729 | 2.870 |
Why?
|
| Aspartic Acid Endopeptidases | 43 | 2019 | 311 | 2.840 |
Why?
|
| Peptide Fragments | 79 | 2023 | 5097 | 2.800 |
Why?
|
| Insulysin | 19 | 2010 | 50 | 2.630 |
Why?
|
| Presenilin-1 | 55 | 2021 | 635 | 2.360 |
Why?
|
| Hippocampus | 37 | 2023 | 3675 | 2.330 |
Why?
|
| Brain | 120 | 2023 | 26385 | 2.210 |
Why?
|
| CHO Cells | 65 | 2016 | 1406 | 2.170 |
Why?
|
| Membrane Proteins | 71 | 2016 | 7880 | 2.160 |
Why?
|
| Cricetinae | 68 | 2014 | 2472 | 1.990 |
Why?
|
| Brain Chemistry | 28 | 2020 | 981 | 1.810 |
Why?
|
| Synapses | 16 | 2022 | 1728 | 1.690 |
Why?
|
| Protein Processing, Post-Translational | 35 | 2018 | 1990 | 1.640 |
Why?
|
| Nerve Tissue Proteins | 38 | 2018 | 4462 | 1.560 |
Why?
|
| Animals | 270 | 2023 | 168757 | 1.560 |
Why?
|
| Thiadiazines | 2 | 2019 | 10 | 1.410 |
Why?
|
| Amyloidosis | 12 | 2022 | 795 | 1.360 |
Why?
|
| Nerve Degeneration | 12 | 2020 | 748 | 1.340 |
Why?
|
| Neuronal Plasticity | 11 | 2020 | 1422 | 1.340 |
Why?
|
| Cell Membrane | 23 | 2021 | 3748 | 1.320 |
Why?
|
| Cricetulus | 26 | 2016 | 816 | 1.230 |
Why?
|
| Microglia | 9 | 2023 | 1266 | 1.200 |
Why?
|
| Inclusion Bodies | 6 | 2021 | 279 | 1.190 |
Why?
|
| Enzyme Inhibitors | 12 | 2021 | 3798 | 1.180 |
Why?
|
| Mice | 107 | 2023 | 81183 | 1.130 |
Why?
|
| Transfection | 49 | 2016 | 5892 | 1.130 |
Why?
|
| Presenilin-2 | 24 | 2007 | 106 | 1.110 |
Why?
|
| Stearoyl-CoA Desaturase | 5 | 2022 | 86 | 1.100 |
Why?
|
| Protein Multimerization | 9 | 2021 | 970 | 1.100 |
Why?
|
| Synaptosomes | 3 | 2021 | 115 | 1.050 |
Why?
|
| Humans | 407 | 2023 | 744343 | 1.000 |
Why?
|
| Amino Acid Sequence | 65 | 2021 | 13815 | 0.970 |
Why?
|
| Neurites | 9 | 2018 | 388 | 0.970 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 19 | 2019 | 3870 | 0.970 |
Why?
|
| Neprilysin | 9 | 2010 | 439 | 0.970 |
Why?
|
| G(M1) Ganglioside | 3 | 2014 | 96 | 0.960 |
Why?
|
| Presenilins | 4 | 2016 | 54 | 0.940 |
Why?
|
| Encephalitis | 2 | 2018 | 423 | 0.930 |
Why?
|
| Substrate Specificity | 21 | 2021 | 1801 | 0.910 |
Why?
|
| Cyclic S-Oxides | 2 | 2019 | 21 | 0.890 |
Why?
|
| Mice, Transgenic | 34 | 2020 | 9734 | 0.880 |
Why?
|
| Protease Inhibitors | 17 | 2016 | 791 | 0.880 |
Why?
|
| Rats | 65 | 2023 | 24260 | 0.850 |
Why?
|
| Cells, Cultured | 50 | 2021 | 19229 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 7 | 2020 | 1061 | 0.840 |
Why?
|
| Scientific Misconduct | 1 | 2022 | 71 | 0.820 |
Why?
|
| Cerebral Cortex | 30 | 2018 | 5708 | 0.820 |
Why?
|
| Parkinsonian Disorders | 3 | 2018 | 275 | 0.820 |
Why?
|
| Cell Line | 56 | 2019 | 15997 | 0.810 |
Why?
|
| Molecular Sequence Data | 65 | 2015 | 18111 | 0.810 |
Why?
|
| Protein Folding | 8 | 2021 | 843 | 0.790 |
Why?
|
| Synaptic Vesicles | 2 | 2021 | 191 | 0.790 |
Why?
|
| Blotting, Western | 27 | 2013 | 5179 | 0.780 |
Why?
|
| beta-Synuclein | 3 | 2021 | 14 | 0.780 |
Why?
|
| Immunoprecipitation | 15 | 2016 | 905 | 0.780 |
Why?
|
| Antiparkinson Agents | 2 | 2018 | 184 | 0.760 |
Why?
|
| Solubility | 19 | 2021 | 1085 | 0.760 |
Why?
|
| Inositol | 2 | 2015 | 218 | 0.750 |
Why?
|
| Mutation | 47 | 2023 | 29786 | 0.730 |
Why?
|
| Exocytosis | 3 | 2021 | 353 | 0.710 |
Why?
|
| Environment | 3 | 2016 | 1124 | 0.700 |
Why?
|
| Mass Media | 1 | 2022 | 305 | 0.690 |
Why?
|
| Biochemistry | 2 | 2018 | 113 | 0.690 |
Why?
|
| Receptors, Adrenergic, beta-2 | 3 | 2017 | 202 | 0.690 |
Why?
|
| Spiro Compounds | 1 | 2019 | 76 | 0.680 |
Why?
|
| Endocytosis | 9 | 2010 | 985 | 0.670 |
Why?
|
| Molecular Weight | 32 | 2017 | 2255 | 0.660 |
Why?
|
| Cytoskeleton | 18 | 2005 | 1185 | 0.660 |
Why?
|
| Lipid Metabolism | 5 | 2021 | 1889 | 0.650 |
Why?
|
| Recombinant Proteins | 22 | 2021 | 6622 | 0.640 |
Why?
|
| Neurofibrils | 18 | 1988 | 76 | 0.630 |
Why?
|
| Neuroprotective Agents | 3 | 2019 | 941 | 0.630 |
Why?
|
| Down Syndrome | 14 | 2023 | 880 | 0.620 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2018 | 246 | 0.610 |
Why?
|
| Protein Precursors | 15 | 1999 | 1154 | 0.610 |
Why?
|
| Clinical Trials as Topic | 10 | 2021 | 7913 | 0.590 |
Why?
|
| Induced Pluripotent Stem Cells | 10 | 2021 | 1736 | 0.580 |
Why?
|
| Disease Models, Animal | 25 | 2023 | 18029 | 0.570 |
Why?
|
| Insulin | 12 | 2012 | 6580 | 0.570 |
Why?
|
| Mice, Inbred C57BL | 25 | 2019 | 21827 | 0.570 |
Why?
|
| Protein Binding | 23 | 2021 | 9386 | 0.560 |
Why?
|
| Lewy Bodies | 6 | 2020 | 137 | 0.560 |
Why?
|
| Signal Transduction | 26 | 2023 | 23403 | 0.560 |
Why?
|
| Apolipoproteins E | 13 | 2018 | 1438 | 0.560 |
Why?
|
| Extracellular Fluid | 3 | 2014 | 167 | 0.550 |
Why?
|
| Synaptic Transmission | 6 | 2022 | 1178 | 0.540 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 1375 | 0.540 |
Why?
|
| Calcium | 8 | 2022 | 5756 | 0.530 |
Why?
|
| Caspase 1 | 1 | 2016 | 224 | 0.530 |
Why?
|
| COS Cells | 12 | 2011 | 1161 | 0.530 |
Why?
|
| Dentate Gyrus | 1 | 2016 | 160 | 0.520 |
Why?
|
| Intermediate Filaments | 9 | 1990 | 175 | 0.520 |
Why?
|
| Models, Biological | 16 | 2021 | 9583 | 0.520 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2015 | 95 | 0.520 |
Why?
|
| Protein Kinases | 5 | 2011 | 1640 | 0.510 |
Why?
|
| Lewy Body Disease | 5 | 2020 | 229 | 0.510 |
Why?
|
| Neurofibrillary Tangles | 10 | 2021 | 439 | 0.500 |
Why?
|
| Biopolymers | 3 | 2014 | 189 | 0.500 |
Why?
|
| Chromatography, Gel | 7 | 2017 | 668 | 0.490 |
Why?
|
| Membrane Glycoproteins | 11 | 2015 | 3768 | 0.490 |
Why?
|
| Peptide Hydrolases | 10 | 2011 | 634 | 0.490 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2008 | 546 | 0.480 |
Why?
|
| Blood-Brain Barrier | 5 | 2011 | 1017 | 0.480 |
Why?
|
| Microtubule-Associated Proteins | 14 | 2016 | 1086 | 0.480 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2011 | 1861 | 0.470 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2018 | 8301 | 0.470 |
Why?
|
| Golgi Apparatus | 11 | 2006 | 410 | 0.470 |
Why?
|
| Protein Stability | 2 | 2014 | 557 | 0.470 |
Why?
|
| Glutamic Acid | 6 | 2018 | 1169 | 0.460 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 140 | 0.450 |
Why?
|
| Mitochondria | 6 | 2014 | 3520 | 0.450 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.450 |
Why?
|
| Aging | 23 | 2011 | 8664 | 0.450 |
Why?
|
| Imidazoles | 1 | 2019 | 1206 | 0.440 |
Why?
|
| Immunoassay | 3 | 2022 | 752 | 0.440 |
Why?
|
| Neurotoxins | 5 | 2009 | 237 | 0.440 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2013 | 895 | 0.430 |
Why?
|
| Memory Disorders | 5 | 2010 | 1184 | 0.430 |
Why?
|
| Dimerization | 14 | 2011 | 893 | 0.430 |
Why?
|
| Mutation, Missense | 10 | 2019 | 2564 | 0.430 |
Why?
|
| Cholesterol | 2 | 2011 | 2917 | 0.420 |
Why?
|
| Membrane Lipids | 2 | 2016 | 248 | 0.420 |
Why?
|
| Culture Media, Conditioned | 11 | 2015 | 537 | 0.420 |
Why?
|
| Receptors, Notch | 14 | 2005 | 739 | 0.420 |
Why?
|
| Protein Structure, Secondary | 9 | 2017 | 1246 | 0.410 |
Why?
|
| Memory | 8 | 2017 | 2174 | 0.410 |
Why?
|
| Cytosol | 11 | 2022 | 901 | 0.410 |
Why?
|
| Drug Design | 3 | 2023 | 1076 | 0.410 |
Why?
|
| Congo Red | 7 | 2004 | 46 | 0.410 |
Why?
|
| Immunohistochemistry | 31 | 2015 | 11366 | 0.410 |
Why?
|
| Models, Molecular | 9 | 2014 | 5456 | 0.400 |
Why?
|
| Lipoylation | 2 | 2023 | 72 | 0.400 |
Why?
|
| Erythroid Cells | 1 | 2013 | 238 | 0.390 |
Why?
|
| Immunoblotting | 9 | 2015 | 1682 | 0.390 |
Why?
|
| HeLa Cells | 11 | 2011 | 3128 | 0.390 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2011 | 293 | 0.390 |
Why?
|
| Mitochondrial Proteins | 4 | 2011 | 996 | 0.380 |
Why?
|
| Phosphorylation | 15 | 2023 | 8436 | 0.380 |
Why?
|
| Protein Conformation | 13 | 2021 | 4011 | 0.380 |
Why?
|
| Aspartic Acid | 4 | 2000 | 576 | 0.380 |
Why?
|
| Polymers | 5 | 2009 | 1621 | 0.370 |
Why?
|
| Drug Discovery | 1 | 2018 | 1058 | 0.370 |
Why?
|
| Metabolomics | 1 | 2018 | 1484 | 0.360 |
Why?
|
| Glycerophospholipids | 1 | 2009 | 32 | 0.350 |
Why?
|
| Receptor, Notch1 | 5 | 2016 | 502 | 0.350 |
Why?
|
| Microscopy, Confocal | 8 | 2013 | 1970 | 0.350 |
Why?
|
| Receptors, AMPA | 3 | 2017 | 331 | 0.340 |
Why?
|
| Neuralgia | 1 | 2016 | 570 | 0.340 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2009 | 59 | 0.340 |
Why?
|
| Fatty Acids | 4 | 2022 | 1809 | 0.330 |
Why?
|
| Cell Movement | 3 | 2012 | 5217 | 0.330 |
Why?
|
| Receptors, Cell Surface | 6 | 2007 | 2866 | 0.330 |
Why?
|
| Phospholipase D | 1 | 2009 | 70 | 0.330 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 18 | 2011 | 1801 | 0.330 |
Why?
|
| Neuroblastoma | 6 | 2020 | 1226 | 0.330 |
Why?
|
| Embryo, Mammalian | 8 | 2017 | 1701 | 0.320 |
Why?
|
| Subcellular Fractions | 8 | 2011 | 547 | 0.320 |
Why?
|
| Conserved Sequence | 5 | 2021 | 1202 | 0.310 |
Why?
|
| Hydrolysis | 11 | 2009 | 682 | 0.310 |
Why?
|
| Half-Life | 4 | 2019 | 661 | 0.310 |
Why?
|
| Chaperonins | 1 | 2007 | 62 | 0.310 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2219 | 0.310 |
Why?
|
| Microscopy, Electron | 19 | 2009 | 2645 | 0.310 |
Why?
|
| Coloring Agents | 4 | 2000 | 566 | 0.310 |
Why?
|
| Sodium Dodecyl Sulfate | 6 | 2010 | 131 | 0.310 |
Why?
|
| Extracellular Space | 6 | 2018 | 594 | 0.300 |
Why?
|
| Patch-Clamp Techniques | 6 | 2015 | 964 | 0.300 |
Why?
|
| Dopamine | 2 | 2005 | 1591 | 0.300 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2016 | 1414 | 0.290 |
Why?
|
| Antibodies | 7 | 2022 | 2460 | 0.290 |
Why?
|
| Precipitin Tests | 9 | 2005 | 829 | 0.290 |
Why?
|
| Proteomics | 3 | 2021 | 3638 | 0.290 |
Why?
|
| Serine Endopeptidases | 4 | 2017 | 1072 | 0.290 |
Why?
|
| Nerve Net | 4 | 2012 | 2174 | 0.290 |
Why?
|
| Protein Structure, Tertiary | 12 | 2010 | 3846 | 0.280 |
Why?
|
| Protein Transport | 6 | 2020 | 1988 | 0.280 |
Why?
|
| Synucleins | 5 | 2004 | 110 | 0.280 |
Why?
|
| Lipids | 5 | 2021 | 3305 | 0.280 |
Why?
|
| Chromosome Pairing | 1 | 2006 | 47 | 0.270 |
Why?
|
| Mice, Knockout | 18 | 2023 | 14557 | 0.270 |
Why?
|
| Enzyme Activation | 11 | 2012 | 3701 | 0.270 |
Why?
|
| Structure-Activity Relationship | 11 | 2016 | 3129 | 0.270 |
Why?
|
| Captopril | 2 | 2007 | 272 | 0.270 |
Why?
|
| Anticholesteremic Agents | 2 | 2011 | 979 | 0.270 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2017 | 849 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2005 | 11 | 0.270 |
Why?
|
| Dendritic Spines | 4 | 2013 | 233 | 0.260 |
Why?
|
| Cell Nucleus | 5 | 2003 | 2969 | 0.260 |
Why?
|
| Apolipoprotein E4 | 4 | 2023 | 668 | 0.260 |
Why?
|
| Ketones | 4 | 2000 | 188 | 0.260 |
Why?
|
| Excitatory Postsynaptic Potentials | 6 | 2015 | 377 | 0.260 |
Why?
|
| Periodicals as Topic | 2 | 2018 | 1432 | 0.260 |
Why?
|
| Molecular Biology | 4 | 2008 | 596 | 0.260 |
Why?
|
| Biological Transport | 9 | 2009 | 2118 | 0.260 |
Why?
|
| Kinetics | 12 | 2016 | 6473 | 0.260 |
Why?
|
| Mass Spectrometry | 7 | 2016 | 2203 | 0.250 |
Why?
|
| Codon, Initiator | 1 | 2004 | 52 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2021 | 1213 | 0.250 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 1151 | 0.250 |
Why?
|
| Wakefulness | 1 | 2011 | 1245 | 0.250 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2007 | 365 | 0.250 |
Why?
|
| Cognition Disorders | 10 | 2016 | 4043 | 0.250 |
Why?
|
| Medicare | 1 | 2022 | 6566 | 0.240 |
Why?
|
| Microdialysis | 2 | 2016 | 158 | 0.240 |
Why?
|
| Dementia | 14 | 2012 | 2518 | 0.240 |
Why?
|
| Microscopy, Fluorescence | 6 | 2017 | 2699 | 0.240 |
Why?
|
| Intracellular Fluid | 3 | 2003 | 203 | 0.240 |
Why?
|
| Biotinylation | 4 | 2010 | 179 | 0.240 |
Why?
|
| Lysosomes | 6 | 1996 | 893 | 0.240 |
Why?
|
| Analysis of Variance | 6 | 2015 | 6365 | 0.240 |
Why?
|
| Methionine | 5 | 2004 | 590 | 0.240 |
Why?
|
| Environmental Exposure | 1 | 2018 | 4234 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 8 | 2008 | 1723 | 0.230 |
Why?
|
| C-Peptide | 3 | 2012 | 419 | 0.230 |
Why?
|
| Aged | 60 | 2022 | 163280 | 0.230 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2017 | 265 | 0.230 |
Why?
|
| Cell Death | 7 | 2020 | 1706 | 0.230 |
Why?
|
| HEK293 Cells | 5 | 2019 | 4204 | 0.230 |
Why?
|
| Receptor, Insulin | 1 | 2007 | 846 | 0.230 |
Why?
|
| Tauopathies | 2 | 2018 | 307 | 0.230 |
Why?
|
| Catalytic Domain | 4 | 2016 | 698 | 0.230 |
Why?
|
| Ligases | 2 | 2002 | 333 | 0.230 |
Why?
|
| Paraquat | 1 | 2023 | 34 | 0.230 |
Why?
|
| Macromolecular Substances | 8 | 2004 | 1454 | 0.230 |
Why?
|
| Metalloendopeptidases | 3 | 2003 | 396 | 0.220 |
Why?
|
| RNA Interference | 3 | 2011 | 2889 | 0.220 |
Why?
|
| Synaptotagmins | 1 | 2023 | 58 | 0.220 |
Why?
|
| Pyridazines | 2 | 2020 | 202 | 0.220 |
Why?
|
| Cell Polarity | 3 | 1995 | 645 | 0.220 |
Why?
|
| Metabolome | 1 | 2009 | 895 | 0.210 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2022 | 30 | 0.210 |
Why?
|
| Up-Regulation | 6 | 2020 | 4217 | 0.210 |
Why?
|
| ADAM Proteins | 3 | 2015 | 243 | 0.210 |
Why?
|
| Oleic Acid | 2 | 2018 | 85 | 0.210 |
Why?
|
| Endoplasmic Reticulum | 5 | 2009 | 1144 | 0.210 |
Why?
|
| D-Aspartic Acid | 1 | 2002 | 4 | 0.210 |
Why?
|
| Calpain | 1 | 2023 | 150 | 0.210 |
Why?
|
| gamma-Synuclein | 1 | 2021 | 10 | 0.210 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 1518 | 0.210 |
Why?
|
| Base Sequence | 18 | 2007 | 12797 | 0.200 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 2021 | 2557 | 0.200 |
Why?
|
| Astrocytes | 4 | 1997 | 1270 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 18 | 2023 | 9274 | 0.200 |
Why?
|
| Transglutaminases | 2 | 2002 | 194 | 0.200 |
Why?
|
| Neural Stem Cells | 3 | 2018 | 851 | 0.200 |
Why?
|
| Neuroglia | 8 | 2010 | 927 | 0.200 |
Why?
|
| SNARE Proteins | 1 | 2021 | 88 | 0.200 |
Why?
|
| Male | 61 | 2022 | 350118 | 0.200 |
Why?
|
| Ubiquitins | 2 | 2001 | 384 | 0.190 |
Why?
|
| Antigens | 3 | 2002 | 1466 | 0.190 |
Why?
|
| Amyloidogenic Proteins | 1 | 2021 | 152 | 0.190 |
Why?
|
| Neural Inhibition | 2 | 2018 | 602 | 0.190 |
Why?
|
| Glucosylceramidase | 1 | 2021 | 124 | 0.190 |
Why?
|
| Multienzyme Complexes | 3 | 2019 | 686 | 0.190 |
Why?
|
| Nervous System | 3 | 2003 | 554 | 0.190 |
Why?
|
| Phagocytosis | 2 | 2016 | 1539 | 0.190 |
Why?
|
| Female | 64 | 2022 | 380194 | 0.190 |
Why?
|
| Thiadiazoles | 1 | 2020 | 55 | 0.190 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2001 | 195 | 0.180 |
Why?
|
| Iodine Isotopes | 2 | 2011 | 90 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2009 | 3772 | 0.180 |
Why?
|
| Phenylalanine | 4 | 2015 | 365 | 0.180 |
Why?
|
| Oligopeptides | 6 | 2004 | 1189 | 0.180 |
Why?
|
| Epilepsy | 1 | 2016 | 3310 | 0.180 |
Why?
|
| Excitatory Amino Acid Antagonists | 4 | 2011 | 449 | 0.180 |
Why?
|
| Nuclear Proteins | 4 | 2003 | 5853 | 0.180 |
Why?
|
| gamma-Aminobutyric Acid | 3 | 2015 | 1121 | 0.180 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2001 | 443 | 0.180 |
Why?
|
| Protein Kinase C | 6 | 1997 | 1227 | 0.180 |
Why?
|
| Housing, Animal | 1 | 2019 | 48 | 0.180 |
Why?
|
| Electroporation | 3 | 2012 | 251 | 0.180 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 1678 | 0.180 |
Why?
|
| Alternative Splicing | 1 | 2005 | 1117 | 0.180 |
Why?
|
| Kidney | 15 | 2004 | 7186 | 0.180 |
Why?
|
| Electrophysiology | 5 | 2007 | 1308 | 0.170 |
Why?
|
| Reference Values | 10 | 2008 | 4982 | 0.170 |
Why?
|
| Binding Sites | 9 | 2008 | 6114 | 0.170 |
Why?
|
| Calibration | 1 | 2022 | 816 | 0.170 |
Why?
|
| Protein Sorting Signals | 2 | 2002 | 281 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 4 | 2009 | 2088 | 0.170 |
Why?
|
| Neurosecretory Systems | 1 | 2000 | 231 | 0.170 |
Why?
|
| Molecular Mimicry | 2 | 2000 | 201 | 0.170 |
Why?
|
| Apraxias | 1 | 2019 | 64 | 0.170 |
Why?
|
| Lipid Bilayers | 3 | 2015 | 381 | 0.160 |
Why?
|
| Naphthalenes | 2 | 2016 | 194 | 0.160 |
Why?
|
| Diglycerides | 1 | 2018 | 176 | 0.160 |
Why?
|
| Point Mutation | 5 | 2000 | 1623 | 0.160 |
Why?
|
| Acetylation | 3 | 2017 | 1085 | 0.160 |
Why?
|
| Fibroblasts | 8 | 2007 | 4161 | 0.160 |
Why?
|
| Isoproterenol | 1 | 2018 | 399 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 17446 | 0.160 |
Why?
|
| Immunotherapy | 3 | 2023 | 4445 | 0.160 |
Why?
|
| Amino Acid Substitution | 9 | 2008 | 1791 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 3617 | 0.160 |
Why?
|
| Glycoproteins | 4 | 2013 | 2263 | 0.150 |
Why?
|
| Levodopa | 1 | 2018 | 219 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 1995 | 299 | 0.150 |
Why?
|
| PC12 Cells | 5 | 2009 | 330 | 0.150 |
Why?
|
| Microsomes | 4 | 2002 | 257 | 0.150 |
Why?
|
| Age Factors | 10 | 2014 | 18370 | 0.150 |
Why?
|
| RNA, Messenger | 8 | 2016 | 13033 | 0.150 |
Why?
|
| Amino Acid Motifs | 2 | 2015 | 936 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2004 | 1116 | 0.150 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2002 | 703 | 0.150 |
Why?
|
| Proteins | 3 | 2016 | 6103 | 0.150 |
Why?
|
| Triglycerides | 3 | 2018 | 2454 | 0.150 |
Why?
|
| Detergents | 3 | 2004 | 230 | 0.150 |
Why?
|
| Cathepsins | 2 | 1995 | 241 | 0.150 |
Why?
|
| Confusion | 1 | 2019 | 275 | 0.150 |
Why?
|
| Time Factors | 15 | 2015 | 40075 | 0.150 |
Why?
|
| Sirtuin 2 | 1 | 2017 | 97 | 0.150 |
Why?
|
| Genetic Vectors | 4 | 2011 | 3420 | 0.150 |
Why?
|
| Glycosylation | 4 | 2002 | 1126 | 0.150 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2004 | 1085 | 0.150 |
Why?
|
| Drosophila Proteins | 3 | 2011 | 1703 | 0.150 |
Why?
|
| Circular Dichroism | 3 | 2014 | 354 | 0.150 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 1996 | 179 | 0.150 |
Why?
|
| Deoxyuridine | 1 | 2016 | 33 | 0.150 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2018 | 346 | 0.140 |
Why?
|
| Sequence Deletion | 4 | 2015 | 1526 | 0.140 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 1998 | 286 | 0.140 |
Why?
|
| Zebrafish Proteins | 1 | 2003 | 1005 | 0.140 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3255 | 0.140 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2003 | 852 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 10943 | 0.140 |
Why?
|
| alpha-Macroglobulins | 1 | 1996 | 64 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 1081 | 0.140 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2018 | 2752 | 0.140 |
Why?
|
| Protein Structure, Quaternary | 2 | 2015 | 436 | 0.140 |
Why?
|
| Locus Coeruleus | 2 | 2005 | 176 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 3462 | 0.140 |
Why?
|
| Complement C1q | 1 | 2016 | 92 | 0.140 |
Why?
|
| Enzyme Assays | 1 | 2016 | 111 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2016 | 6600 | 0.130 |
Why?
|
| Benzothiazoles | 3 | 2014 | 248 | 0.130 |
Why?
|
| Gangliosides | 2 | 2014 | 137 | 0.130 |
Why?
|
| Phenotype | 9 | 2020 | 16365 | 0.130 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 12072 | 0.130 |
Why?
|
| Dilatation | 1 | 2017 | 291 | 0.130 |
Why?
|
| Aged, 80 and over | 24 | 2019 | 57776 | 0.130 |
Why?
|
| Cell-Free System | 3 | 2000 | 344 | 0.130 |
Why?
|
| Caffeine | 2 | 1997 | 699 | 0.130 |
Why?
|
| Cryoelectron Microscopy | 2 | 2009 | 571 | 0.130 |
Why?
|
| Propanolamines | 1 | 2016 | 167 | 0.130 |
Why?
|
| Ligands | 4 | 2017 | 3282 | 0.130 |
Why?
|
| Benzofurans | 1 | 2016 | 140 | 0.130 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2017 | 1341 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7279 | 0.130 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2007 | 859 | 0.130 |
Why?
|
| Neoplasm Proteins | 2 | 2013 | 3703 | 0.130 |
Why?
|
| Ryanodine | 2 | 2009 | 47 | 0.130 |
Why?
|
| Chemical Precipitation | 1 | 2014 | 179 | 0.130 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 294 | 0.130 |
Why?
|
| Clathrin | 3 | 2010 | 267 | 0.130 |
Why?
|
| Protein Subunits | 3 | 2009 | 959 | 0.130 |
Why?
|
| Hypothalamus | 1 | 2000 | 1063 | 0.130 |
Why?
|
| Neurobiology | 1 | 2016 | 121 | 0.130 |
Why?
|
| Proton-Translocating ATPases | 1 | 1995 | 116 | 0.130 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 9959 | 0.130 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 305 | 0.130 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 728 | 0.120 |
Why?
|
| Intermediate Filament Proteins | 5 | 1986 | 269 | 0.120 |
Why?
|
| Plasmids | 4 | 2011 | 2307 | 0.120 |
Why?
|
| Immunoenzyme Techniques | 9 | 2002 | 1799 | 0.120 |
Why?
|
| Cheirogaleidae | 1 | 1994 | 9 | 0.120 |
Why?
|
| Calcimycin | 1 | 1994 | 222 | 0.120 |
Why?
|
| Catalysis | 3 | 2007 | 761 | 0.120 |
Why?
|
| Tyrosine | 1 | 2018 | 1461 | 0.120 |
Why?
|
| Metalloproteases | 2 | 2011 | 62 | 0.120 |
Why?
|
| Mosaicism | 1 | 2017 | 441 | 0.120 |
Why?
|
| Chronic Disease | 2 | 2007 | 9146 | 0.120 |
Why?
|
| Eye Movements | 4 | 1981 | 507 | 0.120 |
Why?
|
| Vaccines | 1 | 2002 | 822 | 0.120 |
Why?
|
| trans-Golgi Network | 2 | 2003 | 33 | 0.120 |
Why?
|
| Valine | 3 | 2004 | 413 | 0.120 |
Why?
|
| Macrolides | 1 | 1995 | 201 | 0.120 |
Why?
|
| Threonine | 2 | 2023 | 279 | 0.120 |
Why?
|
| Mice, Inbred DBA | 3 | 2009 | 642 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 720 | 0.120 |
Why?
|
| Models, Neurological | 5 | 2008 | 1774 | 0.120 |
Why?
|
| Sulfones | 1 | 1996 | 437 | 0.120 |
Why?
|
| Sequence Alignment | 3 | 2009 | 2256 | 0.120 |
Why?
|
| Crystallography, X-Ray | 2 | 2010 | 2011 | 0.120 |
Why?
|
| Serum Albumin | 1 | 1996 | 676 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2003 | 2421 | 0.110 |
Why?
|
| Stereoisomerism | 2 | 2006 | 624 | 0.110 |
Why?
|
| Protein Isoforms | 3 | 2015 | 1730 | 0.110 |
Why?
|
| Aluminum | 3 | 1985 | 152 | 0.110 |
Why?
|
| Middle Aged | 45 | 2020 | 213383 | 0.110 |
Why?
|
| Isoenzymes | 3 | 2005 | 1726 | 0.110 |
Why?
|
| Genetic Loci | 1 | 2023 | 2575 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2007 | 287 | 0.110 |
Why?
|
| Erythrocytes | 2 | 2014 | 2455 | 0.110 |
Why?
|
| Multiprotein Complexes | 3 | 2009 | 1119 | 0.110 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 293 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2015 | 500 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2019 | 2618 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2014 | 297 | 0.110 |
Why?
|
| Amides | 1 | 2016 | 459 | 0.110 |
Why?
|
| Cimicifuga | 1 | 2012 | 5 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 7 | 2010 | 2505 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2014 | 596 | 0.110 |
Why?
|
| Substantia Nigra | 3 | 2017 | 353 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2019 | 3752 | 0.110 |
Why?
|
| Sweden | 5 | 1999 | 1345 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1114 | 0.110 |
Why?
|
| Immunologic Techniques | 4 | 1991 | 218 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 534 | 0.110 |
Why?
|
| Neurofilament Proteins | 5 | 2020 | 318 | 0.110 |
Why?
|
| Cholic Acids | 2 | 2003 | 41 | 0.110 |
Why?
|
| Electrophoresis | 3 | 1999 | 240 | 0.110 |
Why?
|
| Plant Roots | 1 | 2012 | 109 | 0.110 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 104 | 0.100 |
Why?
|
| Heparin | 2 | 2009 | 1637 | 0.100 |
Why?
|
| Cross-Linking Reagents | 1 | 2015 | 694 | 0.100 |
Why?
|
| Dogs | 4 | 2008 | 3912 | 0.100 |
Why?
|
| Glycerol | 2 | 2011 | 278 | 0.100 |
Why?
|
| Microsomes, Liver | 3 | 2016 | 173 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2008 | 1157 | 0.100 |
Why?
|
| Epitopes | 11 | 2010 | 2571 | 0.100 |
Why?
|
| Cell Communication | 2 | 2012 | 1621 | 0.100 |
Why?
|
| Peptides | 7 | 2004 | 4409 | 0.100 |
Why?
|
| Cognition | 6 | 2023 | 6770 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1996 | 878 | 0.100 |
Why?
|
| Gene Expression | 8 | 2005 | 7799 | 0.100 |
Why?
|
| Lactase | 1 | 2011 | 69 | 0.100 |
Why?
|
| Chromosomes | 1 | 1995 | 596 | 0.100 |
Why?
|
| Terminology as Topic | 1 | 1999 | 1547 | 0.100 |
Why?
|
| Antibody Specificity | 3 | 2009 | 1095 | 0.100 |
Why?
|
| Culture Media | 3 | 1999 | 908 | 0.100 |
Why?
|
| Exons | 5 | 2005 | 2437 | 0.100 |
Why?
|
| Pyridones | 1 | 2016 | 712 | 0.100 |
Why?
|
| PubMed | 1 | 2011 | 123 | 0.100 |
Why?
|
| Macaca fascicularis | 2 | 2004 | 915 | 0.100 |
Why?
|
| Lentivirus | 2 | 2011 | 501 | 0.100 |
Why?
|
| Mental Processes | 1 | 1992 | 249 | 0.100 |
Why?
|
| Ammonium Chloride | 4 | 1995 | 74 | 0.100 |
Why?
|
| Gene Deletion | 2 | 2017 | 2751 | 0.100 |
Why?
|
| Thiophenes | 1 | 2015 | 588 | 0.100 |
Why?
|
| Insurance Coverage | 1 | 2022 | 1901 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2013 | 315 | 0.100 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 813 | 0.100 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2021 | 3760 | 0.100 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 1152 | 0.100 |
Why?
|
| Myositis | 1 | 1994 | 251 | 0.100 |
Why?
|
| Immune Sera | 5 | 1990 | 641 | 0.100 |
Why?
|
| Microscopy, Immunoelectron | 4 | 2006 | 319 | 0.100 |
Why?
|
| HLA-DR Antigens | 2 | 2009 | 645 | 0.100 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 200 | 0.090 |
Why?
|
| Administration, Intranasal | 3 | 2001 | 446 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2016 | 942 | 0.090 |
Why?
|
| Rats, Long-Evans | 2 | 2002 | 387 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.090 |
Why?
|
| Radioisotopes | 1 | 2012 | 499 | 0.090 |
Why?
|
| Immunization | 3 | 2005 | 1256 | 0.090 |
Why?
|
| Cell Line, Tumor | 4 | 2020 | 16689 | 0.090 |
Why?
|
| Cerebellum | 5 | 1996 | 1488 | 0.090 |
Why?
|
| Haplorhini | 4 | 1999 | 552 | 0.090 |
Why?
|
| Erythropoiesis | 1 | 2014 | 705 | 0.090 |
Why?
|
| Blood Vessels | 3 | 1994 | 1125 | 0.090 |
Why?
|
| Diazepam | 2 | 1981 | 205 | 0.090 |
Why?
|
| Leupeptins | 4 | 1993 | 122 | 0.090 |
Why?
|
| Organ Specificity | 3 | 2005 | 2008 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 697 | 0.090 |
Why?
|
| Models, Genetic | 3 | 2007 | 3494 | 0.090 |
Why?
|
| Homeostasis | 4 | 2022 | 3340 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 643 | 0.090 |
Why?
|
| Cerebral Arteries | 1 | 1992 | 494 | 0.090 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2009 | 94 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2020 | 2616 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 1419 | 0.090 |
Why?
|
| Bicuculline | 1 | 2009 | 99 | 0.090 |
Why?
|
| Thiazoles | 3 | 2014 | 1483 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 898 | 0.090 |
Why?
|
| Injections, Intraventricular | 2 | 2006 | 230 | 0.090 |
Why?
|
| Physical Conditioning, Animal | 1 | 2013 | 362 | 0.090 |
Why?
|
| Microtubules | 4 | 2011 | 1090 | 0.090 |
Why?
|
| GABA Antagonists | 1 | 2009 | 128 | 0.090 |
Why?
|
| Enzyme Activators | 1 | 2009 | 57 | 0.090 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1995 | 708 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 644 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2011 | 502 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 471 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2915 | 0.080 |
Why?
|
| Chromatography, Liquid | 2 | 2012 | 976 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2015 | 838 | 0.080 |
Why?
|
| Muscles | 1 | 1994 | 1614 | 0.080 |
Why?
|
| Peptide Library | 1 | 2010 | 349 | 0.080 |
Why?
|
| Cell Differentiation | 8 | 2018 | 11483 | 0.080 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 3505 | 0.080 |
Why?
|
| Saccades | 2 | 1981 | 246 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2013 | 537 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 1993 | 970 | 0.080 |
Why?
|
| Rabbits | 7 | 2009 | 4894 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 21 | 4 | 1989 | 230 | 0.080 |
Why?
|
| Anterior Horn Cells | 1 | 1988 | 19 | 0.080 |
Why?
|
| Proteolipids | 1 | 2008 | 117 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2001 | 5021 | 0.080 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4320 | 0.080 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2009 | 281 | 0.080 |
Why?
|
| Biophysics | 1 | 2009 | 383 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2015 | 3309 | 0.080 |
Why?
|
| Molecular Probes | 2 | 2000 | 316 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2002 | 3079 | 0.080 |
Why?
|
| Learning | 2 | 2008 | 1713 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 19905 | 0.080 |
Why?
|
| Fibrinolysin | 2 | 2008 | 131 | 0.080 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 108 | 0.080 |
Why?
|
| Protease Nexins | 1 | 2007 | 40 | 0.080 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 249 | 0.080 |
Why?
|
| Alzheimer Vaccines | 2 | 2004 | 25 | 0.080 |
Why?
|
| Verapamil | 1 | 2008 | 244 | 0.070 |
Why?
|
| Microcirculation | 1 | 1992 | 1286 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2019 | 880 | 0.070 |
Why?
|
| Axonal Transport | 2 | 1985 | 177 | 0.070 |
Why?
|
| Meninges | 1 | 1988 | 190 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
| Homebound Persons | 1 | 2007 | 49 | 0.070 |
Why?
|
| Mifepristone | 1 | 2008 | 150 | 0.070 |
Why?
|
| Sulfhydryl Compounds | 1 | 2008 | 298 | 0.070 |
Why?
|
| Transcription Factors | 4 | 2000 | 12208 | 0.070 |
Why?
|
| Drug Interactions | 2 | 2009 | 1460 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 871 | 0.070 |
Why?
|
| Brain Diseases | 3 | 1996 | 1563 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2010 | 493 | 0.070 |
Why?
|
| Skin | 4 | 1995 | 4364 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 1995 | 2050 | 0.070 |
Why?
|
| Gliosis | 1 | 2007 | 245 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2005 | 2025 | 0.070 |
Why?
|
| Proline | 2 | 2023 | 458 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 2009 | 1767 | 0.070 |
Why?
|
| Disease Progression | 4 | 2012 | 13284 | 0.070 |
Why?
|
| Lymphocytes | 2 | 2007 | 2617 | 0.070 |
Why?
|
| Sulfur Radioisotopes | 3 | 1995 | 116 | 0.070 |
Why?
|
| Principal Component Analysis | 1 | 2009 | 940 | 0.070 |
Why?
|
| Secondary Prevention | 1 | 2012 | 1530 | 0.070 |
Why?
|
| Protein Denaturation | 1 | 2006 | 237 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 5 | 2002 | 6314 | 0.070 |
Why?
|
| Methadone | 4 | 1981 | 306 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 4026 | 0.070 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2005 | 10 | 0.070 |
Why?
|
| Serine | 2 | 2023 | 826 | 0.070 |
Why?
|
| Biotin | 2 | 2000 | 254 | 0.070 |
Why?
|
| Immunization, Passive | 1 | 2008 | 623 | 0.070 |
Why?
|
| Axons | 4 | 2005 | 1684 | 0.070 |
Why?
|
| Adult | 30 | 2022 | 214055 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2016 | 2942 | 0.070 |
Why?
|
| Immunosorbent Techniques | 3 | 1994 | 184 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2000 | 9648 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 1993 | 1741 | 0.060 |
Why?
|
| Submitochondrial Particles | 1 | 2004 | 5 | 0.060 |
Why?
|
| Inflammation | 3 | 2002 | 10638 | 0.060 |
Why?
|
| Diamines | 1 | 2005 | 59 | 0.060 |
Why?
|
| Transplants | 1 | 2007 | 209 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2011 | 875 | 0.060 |
Why?
|
| Cytoplasm | 5 | 1996 | 1539 | 0.060 |
Why?
|
| Cell Fractionation | 2 | 2000 | 252 | 0.060 |
Why?
|
| Sulindac | 1 | 2004 | 29 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2010 | 3002 | 0.060 |
Why?
|
| Dopamine Agents | 1 | 2005 | 189 | 0.060 |
Why?
|
| Staining and Labeling | 3 | 1996 | 1100 | 0.060 |
Why?
|
| Transcription Initiation Site | 1 | 2005 | 196 | 0.060 |
Why?
|
| Gene Dosage | 1 | 2009 | 1252 | 0.060 |
Why?
|
| Tissue Distribution | 3 | 1997 | 2327 | 0.060 |
Why?
|
| Histocytochemistry | 4 | 1992 | 719 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2008 | 690 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10481 | 0.060 |
Why?
|
| Iodine Radioisotopes | 2 | 1999 | 1032 | 0.060 |
Why?
|
| Carbon Radioisotopes | 1 | 2005 | 577 | 0.060 |
Why?
|
| Choline O-Acetyltransferase | 2 | 1987 | 150 | 0.060 |
Why?
|
| Models, Chemical | 2 | 2003 | 626 | 0.060 |
Why?
|
| Dynamin I | 1 | 2003 | 17 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2000 | 1572 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 14722 | 0.060 |
Why?
|
| Rats, Wistar | 4 | 2010 | 1901 | 0.060 |
Why?
|
| Methamphetamine | 1 | 2005 | 154 | 0.060 |
Why?
|
| Monensin | 2 | 1993 | 29 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1343 | 0.060 |
Why?
|
| Huntington Disease | 2 | 1982 | 1124 | 0.060 |
Why?
|
| Age of Onset | 4 | 2000 | 3271 | 0.060 |
Why?
|
| Central Nervous System | 2 | 2004 | 1357 | 0.060 |
Why?
|
| Brefeldin A | 2 | 1993 | 72 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 1991 | 1364 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 1986 | 546 | 0.060 |
Why?
|
| Cysteine | 1 | 2008 | 874 | 0.060 |
Why?
|
| Genotype | 4 | 2002 | 12951 | 0.060 |
Why?
|
| Glucagon | 2 | 2010 | 533 | 0.060 |
Why?
|
| COP-Coated Vesicles | 1 | 2003 | 41 | 0.060 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2003 | 69 | 0.060 |
Why?
|
| Uterus | 1 | 2007 | 711 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1159 | 0.060 |
Why?
|
| Densitometry | 1 | 2003 | 156 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2007 | 749 | 0.060 |
Why?
|
| Fluorescence Polarization | 1 | 2003 | 132 | 0.060 |
Why?
|
| Cyclopentanes | 2 | 1993 | 91 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3086 | 0.060 |
Why?
|
| Macaca mulatta | 5 | 1993 | 2375 | 0.060 |
Why?
|
| Educational Status | 1 | 2011 | 2540 | 0.060 |
Why?
|
| Positron-Emission Tomography | 2 | 2012 | 6234 | 0.060 |
Why?
|
| Cytokines | 2 | 2016 | 7322 | 0.050 |
Why?
|
| Biotechnology | 1 | 2005 | 281 | 0.050 |
Why?
|
| Piperidines | 1 | 2011 | 1602 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 361 | 0.050 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2003 | 142 | 0.050 |
Why?
|
| Motor Neurons | 1 | 1988 | 844 | 0.050 |
Why?
|
| Neurosecretion | 1 | 2002 | 11 | 0.050 |
Why?
|
| Behavior | 1 | 2005 | 561 | 0.050 |
Why?
|
| Supraoptic Nucleus | 1 | 2002 | 28 | 0.050 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2004 | 211 | 0.050 |
Why?
|
| Pituitary Gland, Posterior | 1 | 2002 | 43 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9438 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2003 | 865 | 0.050 |
Why?
|
| Pregnancy | 4 | 2010 | 29144 | 0.050 |
Why?
|
| Colchicine | 2 | 1993 | 243 | 0.050 |
Why?
|
| Chromosome Mapping | 4 | 2002 | 4740 | 0.050 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 2356 | 0.050 |
Why?
|
| Coumarins | 1 | 2002 | 119 | 0.050 |
Why?
|
| Microinjections | 2 | 1993 | 327 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.050 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2002 | 113 | 0.050 |
Why?
|
| Longevity | 1 | 2009 | 1070 | 0.050 |
Why?
|
| Antibody Formation | 3 | 2001 | 1402 | 0.050 |
Why?
|
| Tissue Culture Techniques | 2 | 2015 | 290 | 0.050 |
Why?
|
| Pepstatins | 1 | 2000 | 10 | 0.050 |
Why?
|
| Helix-Turn-Helix Motifs | 1 | 2000 | 13 | 0.050 |
Why?
|
| Cell Nucleolus | 1 | 2002 | 166 | 0.050 |
Why?
|
| Blood Platelets | 1 | 1992 | 2508 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2001 | 151 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1403 | 0.050 |
Why?
|
| Life Expectancy | 1 | 2007 | 1184 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2003 | 329 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 35421 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2003 | 1157 | 0.050 |
Why?
|
| Vaccination | 2 | 2003 | 3278 | 0.050 |
Why?
|
| Life Style | 1 | 2012 | 3835 | 0.050 |
Why?
|
| Fluorescence | 1 | 2003 | 751 | 0.050 |
Why?
|
| Acyltransferases | 1 | 1982 | 294 | 0.050 |
Why?
|
| Freezing | 1 | 2001 | 303 | 0.050 |
Why?
|
| Microscopy, Atomic Force | 2 | 2000 | 250 | 0.050 |
Why?
|
| DNA | 7 | 1994 | 7301 | 0.050 |
Why?
|
| Luciferases | 2 | 2000 | 733 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 2020 | 853 | 0.050 |
Why?
|
| United States | 5 | 2022 | 69872 | 0.050 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2004 | 671 | 0.050 |
Why?
|
| Neurons, Efferent | 1 | 2000 | 82 | 0.050 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2020 | 74 | 0.050 |
Why?
|
| Mitochondrial Membranes | 2 | 2011 | 175 | 0.050 |
Why?
|
| Spinal Cord Diseases | 1 | 1983 | 298 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3690 | 0.050 |
Why?
|
| Sensory Thresholds | 1 | 1981 | 391 | 0.050 |
Why?
|
| Cell Adhesion | 3 | 1997 | 3144 | 0.050 |
Why?
|
| Invertebrates | 1 | 2000 | 50 | 0.050 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2020 | 89 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 503 | 0.040 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 192 | 0.040 |
Why?
|
| Cadherins | 1 | 2004 | 907 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2006 | 1354 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2017 | 2504 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 2007 | 2421 | 0.040 |
Why?
|
| Complement C4b | 1 | 2000 | 135 | 0.040 |
Why?
|
| Iraq | 1 | 2019 | 92 | 0.040 |
Why?
|
| Maze Learning | 1 | 2021 | 478 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 1995 | 7181 | 0.040 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2001 | 300 | 0.040 |
Why?
|
| DNA Footprinting | 1 | 1999 | 98 | 0.040 |
Why?
|
| Methyl n-Butyl Ketone | 1 | 1978 | 1 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 2839 | 0.040 |
Why?
|
| Heterochromatin | 1 | 2002 | 296 | 0.040 |
Why?
|
| Hexanes | 1 | 1978 | 7 | 0.040 |
Why?
|
| Mutagenesis | 2 | 2021 | 1266 | 0.040 |
Why?
|
| Cytotoxins | 1 | 2000 | 153 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 474 | 0.040 |
Why?
|
| Electrochemistry | 1 | 1999 | 145 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2016 | 12261 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2011 | 4217 | 0.040 |
Why?
|
| Pericytes | 1 | 2002 | 292 | 0.040 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 1989 | 20 | 0.040 |
Why?
|
| Wnt Proteins | 1 | 2003 | 721 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1285 | 0.040 |
Why?
|
| Coenzymes | 1 | 1999 | 91 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2006 | 3913 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1979 | 321 | 0.040 |
Why?
|
| Vertebrates | 1 | 2000 | 227 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 2 | 1998 | 563 | 0.040 |
Why?
|
| Radioimmunoassay | 1 | 1999 | 919 | 0.040 |
Why?
|
| X-Ray Diffraction | 3 | 1992 | 420 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 736 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2000 | 1547 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1999 | 286 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2000 | 229 | 0.040 |
Why?
|
| Brain Damage, Chronic | 1 | 1979 | 265 | 0.040 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 15 | 0.040 |
Why?
|
| Ursidae | 2 | 1988 | 26 | 0.040 |
Why?
|
| Lactation | 1 | 2000 | 412 | 0.040 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 1997 | 41 | 0.040 |
Why?
|
| Deoxyribonucleases | 1 | 1999 | 214 | 0.040 |
Why?
|
| Sequence Analysis | 2 | 1999 | 256 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2007 | 2938 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2003 | 6171 | 0.040 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 1998 | 137 | 0.040 |
Why?
|
| Adaptor Protein Complex alpha Subunits | 1 | 1997 | 23 | 0.040 |
Why?
|
| Plasma Volume | 1 | 1997 | 36 | 0.040 |
Why?
|
| Photoaffinity Labels | 2 | 2009 | 86 | 0.040 |
Why?
|
| Genetic Markers | 2 | 2000 | 2634 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 777 | 0.040 |
Why?
|
| Child | 7 | 2020 | 77709 | 0.040 |
Why?
|
| Mice, Inbred A | 1 | 1996 | 248 | 0.040 |
Why?
|
| Tubulin | 2 | 1982 | 695 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 1999 | 1420 | 0.040 |
Why?
|
| Leucine | 1 | 1998 | 561 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15076 | 0.040 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 1997 | 176 | 0.040 |
Why?
|
| Infant | 4 | 2020 | 35136 | 0.040 |
Why?
|
| Spinal Cord | 3 | 1988 | 1809 | 0.040 |
Why?
|
| Amino Alcohols | 1 | 2016 | 16 | 0.040 |
Why?
|
| Complement System Proteins | 1 | 2000 | 795 | 0.040 |
Why?
|
| Albuterol | 1 | 2017 | 208 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63114 | 0.040 |
Why?
|
| Oxytocin | 1 | 2000 | 394 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 683 | 0.040 |
Why?
|
| Parietal Lobe | 1 | 1981 | 838 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7722 | 0.030 |
Why?
|
| Norway | 1 | 2017 | 448 | 0.030 |
Why?
|
| Complement Pathway, Classical | 1 | 2016 | 97 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1996 | 79 | 0.030 |
Why?
|
| Thiamine Deficiency | 1 | 1996 | 43 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2016 | 141 | 0.030 |
Why?
|
| Glutamine | 1 | 1999 | 578 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 1982 | 1221 | 0.030 |
Why?
|
| Neocortex | 3 | 2004 | 400 | 0.030 |
Why?
|
| Brain Stem | 1 | 2001 | 846 | 0.030 |
Why?
|
| Action Potentials | 1 | 2003 | 1806 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1676 | 0.030 |
Why?
|
| Tropanes | 1 | 2015 | 51 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2021 | 2726 | 0.030 |
Why?
|
| Propranolol | 1 | 2017 | 502 | 0.030 |
Why?
|
| Alleles | 3 | 2018 | 6933 | 0.030 |
Why?
|
| Research Design | 1 | 2011 | 5987 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 112 | 0.030 |
Why?
|
| Mitogens | 1 | 1995 | 232 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10397 | 0.030 |
Why?
|
| Sulfuric Acid Esters | 1 | 1995 | 33 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 216 | 0.030 |
Why?
|
| Macrophage-1 Antigen | 1 | 2016 | 290 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 742 | 0.030 |
Why?
|
| Benzylamines | 1 | 2016 | 223 | 0.030 |
Why?
|
| Codon | 2 | 1996 | 611 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1997 | 315 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 386 | 0.030 |
Why?
|
| Membrane Potentials | 2 | 2011 | 1137 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2007 | 712 | 0.030 |
Why?
|
| Stem Cells | 1 | 2007 | 3567 | 0.030 |
Why?
|
| Silver Staining | 1 | 1994 | 64 | 0.030 |
Why?
|
| Tritium | 1 | 1994 | 745 | 0.030 |
Why?
|
| Vacuoles | 1 | 1995 | 230 | 0.030 |
Why?
|
| Ethers, Cyclic | 1 | 1993 | 33 | 0.030 |
Why?
|
| Reading Frames | 1 | 1993 | 18 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2007 | 3748 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1993 | 67 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1995 | 494 | 0.030 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 390 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 1993 | 111 | 0.030 |
Why?
|
| Nocodazole | 1 | 1993 | 97 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2013 | 19 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 944 | 0.030 |
Why?
|
| Receptors, Muscarinic | 1 | 1993 | 156 | 0.030 |
Why?
|
| Exosomes | 1 | 2018 | 417 | 0.030 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1993 | 103 | 0.030 |
Why?
|
| GAP-43 Protein | 1 | 1993 | 152 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2001 | 3023 | 0.030 |
Why?
|
| Rhizome | 1 | 2012 | 8 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 1997 | 798 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 422 | 0.030 |
Why?
|
| Type C Phospholipases | 1 | 1993 | 292 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1994 | 356 | 0.030 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2012 | 22 | 0.030 |
Why?
|
| Germ Cells | 1 | 2017 | 631 | 0.030 |
Why?
|
| Fetus | 1 | 2000 | 1880 | 0.030 |
Why?
|
| Temporal Lobe | 2 | 2002 | 1670 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2015 | 471 | 0.030 |
Why?
|
| Hypotension | 1 | 1979 | 884 | 0.030 |
Why?
|
| Capillaries | 2 | 1994 | 773 | 0.030 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2013 | 77 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 1790 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2019 | 1442 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 767 | 0.030 |
Why?
|
| T-Lymphocytes | 3 | 2009 | 10180 | 0.030 |
Why?
|
| Electrooculography | 3 | 1981 | 118 | 0.030 |
Why?
|
| Triterpenes | 1 | 2012 | 80 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1992 | 878 | 0.030 |
Why?
|
| Pia Mater | 1 | 1992 | 88 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1655 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 2 | 1999 | 2731 | 0.030 |
Why?
|
| Glycosides | 1 | 2012 | 107 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 128 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 15519 | 0.030 |
Why?
|
| Endosomes | 2 | 2006 | 520 | 0.030 |
Why?
|
| Body Fluids | 1 | 1993 | 319 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2009 | 8949 | 0.030 |
Why?
|
| Sciatic Nerve | 3 | 1985 | 607 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 1993 | 399 | 0.030 |
Why?
|
| Carbonates | 1 | 2011 | 21 | 0.030 |
Why?
|
| Umbilical Veins | 1 | 1992 | 433 | 0.030 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 1240 | 0.030 |
Why?
|
| Laminin | 1 | 1993 | 419 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2001 | 2924 | 0.020 |
Why?
|
| Arterioles | 1 | 1992 | 254 | 0.020 |
Why?
|
| Young Adult | 2 | 2020 | 56430 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 809 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 1992 | 403 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1993 | 610 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 2031 | 0.020 |
Why?
|
| Motor Activity | 1 | 2021 | 2714 | 0.020 |
Why?
|
| Research | 1 | 2020 | 1999 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 25043 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1990 | 76 | 0.020 |
Why?
|
| Cerebrosides | 1 | 1970 | 7 | 0.020 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21746 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 1993 | 519 | 0.020 |
Why?
|
| Cognitive Reserve | 1 | 2011 | 76 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4554 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3647 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 536 | 0.020 |
Why?
|
| Phenanthrolines | 1 | 2010 | 55 | 0.020 |
Why?
|
| Risk Factors | 2 | 2020 | 72290 | 0.020 |
Why?
|
| Drug Stability | 1 | 2010 | 291 | 0.020 |
Why?
|
| Amino Acids | 2 | 1986 | 1736 | 0.020 |
Why?
|
| Caveolins | 1 | 2010 | 104 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2002 | 428 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2018 | 40561 | 0.020 |
Why?
|
| Rodentia | 1 | 1991 | 261 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 1420 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1970 | 554 | 0.020 |
Why?
|
| Fibronectins | 1 | 1993 | 726 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12788 | 0.020 |
Why?
|
| Glycine | 2 | 2004 | 671 | 0.020 |
Why?
|
| Carnivora | 1 | 1988 | 29 | 0.020 |
Why?
|
| Histidine | 1 | 2010 | 313 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12959 | 0.020 |
Why?
|
| Lysine | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 549 | 0.020 |
Why?
|
| Adolescent | 5 | 2020 | 85781 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 991 | 0.020 |
Why?
|
| Edetic Acid | 1 | 2009 | 276 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2022 | 12026 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 233 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2020 | 41006 | 0.020 |
Why?
|
| DNA Primers | 3 | 1997 | 2892 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Alkylating Agents | 1 | 2008 | 139 | 0.020 |
Why?
|
| Pantothenate Kinase-Associated Neurodegeneration | 1 | 1987 | 14 | 0.020 |
Why?
|
| Cell Survival | 3 | 2007 | 5882 | 0.020 |
Why?
|
| Pongo pygmaeus | 1 | 1987 | 3 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2000 | 2872 | 0.020 |
Why?
|
| International Cooperation | 1 | 2014 | 1420 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 295 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1991 | 647 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 296 | 0.020 |
Why?
|
| Histones | 1 | 2017 | 2599 | 0.020 |
Why?
|
| Basal Ganglia Diseases | 1 | 1987 | 149 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 1986 | 68 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 3848 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2010 | 6993 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2077 | 0.020 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1969 | 255 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 964 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2015 | 15540 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 1986 | 153 | 0.020 |
Why?
|
| Cerebral Hemorrhage | 4 | 1999 | 2647 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2006 | 191 | 0.020 |
Why?
|
| Saimiri | 1 | 1987 | 330 | 0.020 |
Why?
|
| Education | 1 | 2009 | 543 | 0.020 |
Why?
|
| Pain | 1 | 1981 | 4986 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1997 | 2575 | 0.020 |
Why?
|
| Coat Protein Complex I | 1 | 2006 | 32 | 0.020 |
Why?
|
| Immunity, Cellular | 2 | 2003 | 1607 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1986 | 313 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 627 | 0.020 |
Why?
|
| Alanine | 2 | 2001 | 572 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1990 | 1899 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1916 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 4328 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 1593 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2007 | 404 | 0.020 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2009 | 880 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1987 | 841 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9687 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2455 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2005 | 20129 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1993 | 2440 | 0.020 |
Why?
|
| Vimentin | 1 | 1984 | 261 | 0.010 |
Why?
|
| Family | 1 | 1995 | 3147 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2004 | 112 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2009 | 1284 | 0.010 |
Why?
|
| Atrophy | 1 | 1988 | 1583 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1893 | 0.010 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 466 | 0.010 |
Why?
|
| Conditioning, Operant | 1 | 2004 | 313 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 380 | 0.010 |
Why?
|
| Organ Size | 1 | 1988 | 2252 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2005 | 758 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2012 | 12720 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2007 | 852 | 0.010 |
Why?
|
| Quinoxalines | 1 | 2004 | 290 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2003 | 311 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2011 | 1708 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2015 | 3444 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2004 | 452 | 0.010 |
Why?
|
| Genome, Human | 1 | 2015 | 4420 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3743 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 1998 | 5974 | 0.010 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1982 | 134 | 0.010 |
Why?
|
| Family Health | 1 | 2007 | 1282 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 1983 | 310 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1983 | 517 | 0.010 |
Why?
|
| Formazans | 1 | 2000 | 8 | 0.010 |
Why?
|
| Tarsal Tunnel Syndrome | 1 | 1981 | 9 | 0.010 |
Why?
|
| Putamen | 1 | 1982 | 291 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1997 | 6544 | 0.010 |
Why?
|
| Endopeptidase K | 1 | 2000 | 23 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15165 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1982 | 253 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2000 | 96 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 2000 | 80 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1982 | 528 | 0.010 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1980 | 115 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 2000 | 44 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1981 | 354 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 1982 | 393 | 0.010 |
Why?
|
| Freeze Drying | 1 | 2000 | 98 | 0.010 |
Why?
|
| Affinity Labels | 1 | 2000 | 109 | 0.010 |
Why?
|
| Liposomes | 1 | 2004 | 759 | 0.010 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2000 | 164 | 0.010 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2000 | 121 | 0.010 |
Why?
|
| Static Electricity | 1 | 2000 | 267 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 1866 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 11725 | 0.010 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2000 | 112 | 0.010 |
Why?
|
| Glucosides | 1 | 2004 | 451 | 0.010 |
Why?
|
| Benzamides | 1 | 2005 | 1379 | 0.010 |
Why?
|
| RNA | 1 | 1970 | 2749 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2003 | 1150 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1992 | 4456 | 0.010 |
Why?
|
| Filtration | 1 | 2000 | 234 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2899 | 0.010 |
Why?
|
| Urea | 1 | 1982 | 450 | 0.010 |
Why?
|
| Clusterin | 1 | 2000 | 72 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 824 | 0.010 |
Why?
|
| Ovary | 1 | 2004 | 981 | 0.010 |
Why?
|
| Solvents | 1 | 2000 | 302 | 0.010 |
Why?
|
| Leukocytes | 1 | 1987 | 2043 | 0.010 |
Why?
|
| Complement C4 | 1 | 2000 | 257 | 0.010 |
Why?
|
| Autoantigens | 1 | 2003 | 892 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 4644 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2003 | 721 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2003 | 577 | 0.010 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1998 | 58 | 0.010 |
Why?
|
| Neurocytoma | 1 | 1998 | 30 | 0.010 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 1981 | 356 | 0.010 |
Why?
|
| Triiodobenzoic Acids | 1 | 1998 | 124 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 1101 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2008 | 2050 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1979 | 383 | 0.010 |
Why?
|
| Myelin Sheath | 1 | 1981 | 652 | 0.010 |
Why?
|
| Linear Models | 1 | 2008 | 5952 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 13989 | 0.010 |
Why?
|
| Fluorometry | 1 | 1996 | 106 | 0.010 |
Why?
|
| Apoptosis | 1 | 2013 | 9727 | 0.010 |
Why?
|
| Wernicke Encephalopathy | 1 | 1996 | 28 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 1341 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15226 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2003 | 6256 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1992 | 6669 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 1000 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1996 | 363 | 0.010 |
Why?
|
| Angiography | 1 | 1981 | 1639 | 0.010 |
Why?
|
| Alkylation | 1 | 1995 | 86 | 0.010 |
Why?
|
| Cathepsin L | 1 | 1995 | 75 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 203 | 0.010 |
Why?
|
| Cathepsin D | 1 | 1995 | 61 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2000 | 1997 | 0.010 |
Why?
|
| Cathepsin B | 1 | 1995 | 82 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1984 | 6386 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1995 | 46 | 0.010 |
Why?
|
| Superior Cervical Ganglion | 1 | 1995 | 33 | 0.010 |
Why?
|
| Temperature | 1 | 1981 | 2206 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12245 | 0.010 |
Why?
|
| Piperazines | 1 | 2005 | 2488 | 0.010 |
Why?
|
| Cats | 1 | 1996 | 998 | 0.010 |
Why?
|
| Heart Failure | 1 | 1979 | 10900 | 0.010 |
Why?
|
| Alkaloids | 2 | 1986 | 190 | 0.010 |
Why?
|
| Necrosis | 1 | 1979 | 1643 | 0.010 |
Why?
|
| Pons | 1 | 1975 | 245 | 0.010 |
Why?
|
| Netherlands | 1 | 1999 | 2170 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 434 | 0.010 |
Why?
|
| Brain Edema | 1 | 1979 | 617 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1783 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 3327 | 0.010 |
Why?
|
| Disulfides | 1 | 1995 | 457 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2009 | 4599 | 0.010 |
Why?
|
| Cattle | 1 | 1979 | 3922 | 0.010 |
Why?
|
| Astrocytoma | 1 | 1998 | 790 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1994 | 352 | 0.010 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1992 | 114 | 0.010 |
Why?
|
| Organoids | 1 | 1978 | 701 | 0.010 |
Why?
|
| Comorbidity | 1 | 2007 | 10388 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1994 | 489 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2001 | 2258 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 1979 | 1869 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1998 | 1338 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 1992 | 447 | 0.010 |
Why?
|
| Species Specificity | 2 | 1988 | 2478 | 0.010 |
Why?
|
| Cell Division | 1 | 1978 | 4568 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1970 | 198 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1995 | 2187 | 0.010 |
Why?
|
| Frontal Lobe | 2 | 1982 | 1406 | 0.010 |
Why?
|
| Depression | 1 | 2009 | 7766 | 0.010 |
Why?
|
| Glioma | 2 | 1998 | 3401 | 0.010 |
Why?
|
| Methods | 1 | 1970 | 1129 | 0.010 |
Why?
|
| Chromatography | 1 | 1969 | 206 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 5751 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 1970 | 666 | 0.010 |
Why?
|
| Gestational Age | 1 | 1997 | 3493 | 0.010 |
Why?
|
| Paclitaxel | 2 | 1986 | 1708 | 0.000 |
Why?
|
| Behavior, Animal | 1 | 1996 | 1881 | 0.000 |
Why?
|
| Diet Therapy | 1 | 1969 | 154 | 0.000 |
Why?
|
| Immunochemistry | 1 | 1987 | 124 | 0.000 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1692 | 0.000 |
Why?
|
| Bacteriophage lambda | 1 | 1986 | 147 | 0.000 |
Why?
|
| Seizures | 1 | 1979 | 2859 | 0.000 |
Why?
|
| Somatostatin | 1 | 1987 | 459 | 0.000 |
Why?
|
| Corpus Callosum | 1 | 1970 | 737 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1375 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1979 | 6150 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 53288 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1979 | 8554 | 0.000 |
Why?
|
| Isoelectric Focusing | 1 | 1982 | 181 | 0.000 |
Why?
|
| Glioblastoma | 1 | 1975 | 3481 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1984 | 1182 | 0.000 |
Why?
|
| Spinal Nerve Roots | 1 | 1979 | 121 | 0.000 |
Why?
|
| Foot | 1 | 1981 | 527 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1975 | 8863 | 0.000 |
Why?
|